Call us now on: +44 (0) 1223 743170
Domainex Ltd is a drug discovery company established in 2001 and operating from Cambridge, UK. It is one of the most successful drug discovery service providers in the marketplace, with 3 compounds developed by Domainex's scientists entering the clinic in the last 4 years.
Domainex operates a hybrid business model, offering drug discovery services to external partners, whilst developing its own pipeline of novel oncology drugs.
Domainex's service division offers technologies designed to clone and express drug targets to give high-quality recombinant protein for use in structural studies or for the establishment of activity/ binding assays. It also provides computational and medicinal chemistry for the design and synthesis of candidate drugs aimed at its customers' target proteins.
Domainex would be interested in speaking to potential partners about novel drug discovery on a fee-for-service or collaborative deal basis.